Exabis Library
Welcome to the e-CCO Library!
P295 VALIDation of the IBD-Disk instrument for assessing disability in inflammatory bowel diseases in a population-based cohort: The VALIDate study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P295: Absence of mucosal healing in patients undergoing assessment of mucosal healing with a normal PUCAI score in pediatric ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P295: Comparative Assessment of Infliximab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P295: Correlation between sonographic measurements in inflammatory bowel diseases and biological markers of disease activity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P295: Hocus Pocus: The Role Of Hand-Held Ultrasonography In Predicting Disease Extension And Endoscopic Activity In Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P295: Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P295: Proctitis during Crohn's disease, would it be a factor in the sustainability of anoperineal fistulas ?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P295: The Ulcerative Colitis Endoscopic Index of Severity is useful to predict medium- to long-term prognosis in ulcerative colitis patients with clinical remission
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P296 Quality of reporting of lesions detected at surveillance colonoscopy for IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P296: Effect of upadacitinib on patient-reported symptoms by the new Ulcerative Colitis Symptoms Questionnaire (UC-SQ) in patients with moderate to severe ulcerative colitis: data from the Phase 2b study U-ACHIEVE
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P296: Evaluation of the new liaison faecal calprotectin assay
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P296: Levels of engagement in physical activity and fatigue in IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P296: MAGNIFI-CD index is appropriate for treatment monitoring in perianal Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P296: Stopping 5-aminosalicylic acid in patients with ulcerative colitis who are in clinical remission does not increase risks of flare
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P296: vedolizumab Does Not Increase Risk of Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease Using vedolizumab: a Retrospective Cohort Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P297 Novel serum soluble markers of histological healing in ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P297: Evaluation of the clinical course of Adolescent inflammatory bowel disease patients at Nottingham University Hospital
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remission
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P297: HLA-DQA1*05 allele and its association with the secondary loss of response to infliximab in patients with Inflammatory Bowel Disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM